Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2272 | 4206 | 31.0 | 71% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
357 | 31315 | CONTRACEPTION//EMERGENCY CONTRACEPTION//MEDICAL ABORTION |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
7235 | 1314 | BIOANALYSIS//BIOANALYT METAB PHARMACOKINET//CASSETTE ANALYSIS |
11021 | 948 | LC NMR//HPLC HRMS SPE NMR//MASS LIMITED SAMPLES |
13495 | 769 | REACTIVE METABOLITE//MASS DEFECT FILTER//TIENILIC ACID |
16464 | 587 | ACYL GLUCURONIDES//ACYL GLUCURONIDE//ZOMEPIRAC |
18946 | 462 | DRIED BLOOD SPOT DBS//BIOANALYSIS//DRIED BLOOD SPOTS |
31222 | 126 | CORTISOL METABOLITE//GLUCRONIDE//PHAMACOL THER EUT |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BIOANALYSIS | Journal | 99 | 28% | 7% | 309 |
2 | LC NMR | Author keyword | 36 | 51% | 1% | 51 |
3 | DRIED BLOOD SPOT DBS | Author keyword | 30 | 84% | 0% | 16 |
4 | ACYL GLUCURONIDES | Author keyword | 24 | 68% | 0% | 21 |
5 | PHARMACOKINET DYNAM METAB | Address | 16 | 14% | 3% | 107 |
6 | DRIED BLOOD SPOTS | Author keyword | 13 | 20% | 1% | 57 |
7 | ACYL GLUCURONIDE | Author keyword | 13 | 44% | 1% | 22 |
8 | REACTIVE METABOLITE | Author keyword | 12 | 36% | 1% | 27 |
9 | HPLC HRMS SPE NMR | Author keyword | 12 | 86% | 0% | 6 |
10 | MASS LIMITED SAMPLES | Author keyword | 12 | 86% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LC NMR | 36 | 51% | 1% | 51 | Search LC+NMR | Search LC+NMR |
2 | DRIED BLOOD SPOT DBS | 30 | 84% | 0% | 16 | Search DRIED+BLOOD+SPOT+DBS | Search DRIED+BLOOD+SPOT+DBS |
3 | ACYL GLUCURONIDES | 24 | 68% | 0% | 21 | Search ACYL+GLUCURONIDES | Search ACYL+GLUCURONIDES |
4 | DRIED BLOOD SPOTS | 13 | 20% | 1% | 57 | Search DRIED+BLOOD+SPOTS | Search DRIED+BLOOD+SPOTS |
5 | ACYL GLUCURONIDE | 13 | 44% | 1% | 22 | Search ACYL+GLUCURONIDE | Search ACYL+GLUCURONIDE |
6 | REACTIVE METABOLITE | 12 | 36% | 1% | 27 | Search REACTIVE+METABOLITE | Search REACTIVE+METABOLITE |
7 | HPLC HRMS SPE NMR | 12 | 86% | 0% | 6 | Search HPLC+HRMS+SPE+NMR | Search HPLC+HRMS+SPE+NMR |
8 | MASS LIMITED SAMPLES | 12 | 86% | 0% | 6 | Search MASS+LIMITED+SAMPLES | Search MASS+LIMITED+SAMPLES |
9 | HPLC NMR | 12 | 36% | 1% | 26 | Search HPLC+NMR | Search HPLC+NMR |
10 | DRUG PROTEIN ADDUCTS | 11 | 69% | 0% | 9 | Search DRUG+PROTEIN+ADDUCTS | Search DRUG+PROTEIN+ADDUCTS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | QUANTITATIVE BIOANALYSIS | 80 | 65% | 2% | 77 |
2 | ACYL GLUCURONIDES | 58 | 53% | 2% | 77 |
3 | COUPLED HPLC NMR | 56 | 76% | 1% | 39 |
4 | ASSAY BIAS | 47 | 88% | 1% | 22 |
5 | BIOANALYSIS | 46 | 29% | 3% | 135 |
6 | DRUG METABOLITES | 45 | 43% | 2% | 80 |
7 | ZOMEPIRAC GLUCURONIDE | 45 | 83% | 1% | 25 |
8 | THOROUGH BACKGROUND SUBTRACTION | 42 | 94% | 0% | 15 |
9 | MICROCOIL NMR | 40 | 82% | 1% | 23 |
10 | HPLC NMR | 39 | 58% | 1% | 46 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOANALYSIS | 99 | 28% | 7% | 309 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Ion suppression in mass spectrometry | 2003 | 696 | 13 | 77% |
Matrix effects: The Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry | 2005 | 498 | 36 | 56% |
Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS | 2007 | 238 | 76 | 66% |
AN OVERVIEW OF MATRIX EFFECTS IN LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY | 2011 | 153 | 130 | 44% |
Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry | 2010 | 168 | 75 | 51% |
Key elements of bioanalytical method validation for small molecules | 2007 | 133 | 1 | 100% |
Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions | 2014 | 10 | 77 | 77% |
Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules | 2010 | 213 | 72 | 32% |
Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies | 2014 | 6 | 5 | 100% |
High-throughput quantitative bioanalysis by LC/MS/MS | 2000 | 229 | 47 | 81% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOKINET DYNAM METAB | 16 | 14% | 2.5% | 107 |
2 | BIOANALYT METAB PHARMACOKINET | 10 | 73% | 0.2% | 8 |
3 | CORE TECHNOL AREA ANALYT UNIT | 9 | 83% | 0.1% | 5 |
4 | DRUG METAB SECT | 9 | 83% | 0.1% | 5 |
5 | PHARMACEUT CANDIDATE OPTIMIZAT | 8 | 20% | 0.9% | 36 |
6 | BIOANALYT CORE GRP | 8 | 62% | 0.2% | 8 |
7 | BIOANALYT DISCOVERY ANALYT SCI | 6 | 29% | 0.5% | 19 |
8 | INT DEV BIOMET | 6 | 100% | 0.1% | 4 |
9 | QUOTIENT BIO ANALYT SCI | 6 | 100% | 0.1% | 4 |
10 | INT DEV BIOANAL DRUG METAB | 4 | 75% | 0.1% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000015351 | DOPING CONTROL//EPITESTOSTERONE//DOPING ANALYSIS |
2 | 0.0000012526 | METABONOMICS//METABOLOMICS//METABOLIC PROFILING |
3 | 0.0000010954 | JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY//RAPID COMMUNICATIONS IN MASS SPECTROMETRY//INTERNATIONAL JOURNAL OF MASS SPECTROMETRY |
4 | 0.0000008824 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM |
5 | 0.0000008160 | NSAIDS//NABUMETONE//ROFECOXIB |
6 | 0.0000008160 | CYTOCHROME P450//CYP2D6//PREGNANE X RECEPTOR |
7 | 0.0000008090 | A MCKAY PLOT//TRITIUM NMR//ORTHO LABELLING |
8 | 0.0000007912 | ACCREDITATION AND QUALITY ASSURANCE//PROFICIENCY TESTING//MEASUREMENT UNCERTAINTY |
9 | 0.0000007818 | SIMULATED MOVING BED//JOURNAL OF CHROMATOGRAPHY A//JOURNAL OF CHROMATOGRAPHY |
10 | 0.0000007704 | KERNICTERUS//BILIRUBIN//HYPERBILIRUBINEMIA |